ABOGEN BIOSCIENCES
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.
ABOGEN BIOSCIENCES
Industry:
Biotechnology Genetics Life Science
Founded:
2019-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.41 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Domain Not Resolving Apache Mobile Non Scaleable Content Microsoft Azure DNS Apple Mobile Web App Capable
Similar Organizations
Rejuvenation Technologies
Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres.
Ranok Therapeutics
Ranok is a privately held, pre clinical stage bio company that is pioneering an innovative targeted protein degradation technology.
Neurophth Therapeutics
Neurophth is China's first gene therapy company for ophthalmic diseases.
Nusirt
NuSirt Sciences is a biotechnology company focused on developing products.
Novelty Nobility
Novelty Nobility is a private biotech company focused on the research of novel angiogenesis targets and develop antibody-based therapeutics.
Nirvana Science, Inc.
Nirvana Science, Inc. is a technology development company focused on fluorescent dyes with ultra-narrow spectrums.
Varigen
Varigen Biosciences is developing new technologies for capturing and expressing natural product pathways.
Medilink Therapeutics
Medilink Therapeutics is a biotech company focusing on next-generation antibody-drug conjugate Research & development.
Myricx Pharma
Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors.
Microbia Environnement
Microbia Environnement is a specialized biotechnology company in molecular diagnosis for environmental microbiology and helps organizations.
Medisix Therapeutics
Medisix Therapeutics is a provider of immune engineering company developing novel cellular therapies.
Mammoth Biosciences
Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.
Mirailab Bioscience
Mirailab Bioscience is a biotechnology company developing NMN-based nutraceuticals.
MiNA Therapeutics
MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms.
23andMe
23andMe is a DNA testing technology company that enables its users to access their ancestry, genealogy, and inherited traits.
Lytica Therapeutics
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
LUMICKS
LUMICKS provides single-molecule analysis technologies for cancer research and immunotherapy.
AccuRna
AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid therapeutics, both of short chain and long chain.
Avistone Pharmaceuticals
Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.
Acrigen Biosciences
Acrigen Biosciences is dedicated to making gene editing safe.
Alume Biosciences
Alume Biosciences is a biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use.
AceRNA
AceRNA specializes in the development of patient-centric novel genetic therapies based on evidence-based drug-discovery process.
AntalGenics
AntalGenics is a biotechnology company that develops active molecules for biomedical and dermatological applications.
Ailurus Biotechnology
Ailurus Biotechnology is a synthetic biology platform providing standardize bioware tools for all biodevelopers.
Antengene Corporation
Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor.
Atomis
Atomis provides global solutions for precisely controlling gases.
Enveric Biosciences
Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines.
Element Biosciences
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Esya
Esya is a biotech company that measures, monitors, assist drug development, and pre-assess patient cohorts for treatment.
Enopace Biomedical
Enopace Biomedical is a Biotechnology company that focuses on developing a medical device to treat heart failure.
Evogene
Evogene is a biotechnology company developing novel products for life science markets through the use of a unique CPB platform.
eureKARE
eureKARE is focused on financing and building biotechnology companies in the cutting-edge fields of microbiome and synthetic biology.
Bena Gene
Bena Gene is a gene sequencing service provider, focused on the services and applications of nanopore sequencing technology.
BioStrand
BioStrand is advancing technology for analyzing genetic data, which will drive innovation in the fields of precision medicine.
Benchling
Benchling is a cloud-based software platform for biology researchers and research and development organizations.
Beta Bugs Limited
Beta Bugs is an insect genetics company that develops and distributes high-performance Black Soldier Fly breeds to insect farmers.
Trendlines Group
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies.
Telix Pharmaceuticals
Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.
Ten Bio
Ten Bio is a biotechnology company that provides ex vivo skin culture for research and lab testing.
ToolGen
ToolGen, a biotechnology company, focuses on the development of genome editing technology.
Topas Therapeutics
A biotechnology company focused on developing products to address areas of major unmet need.
TAE Life Sciences
TAE Life Sciences is an pre-clinical biotechnology company developing comprehensive biologically-targeted radiation therapy
Karius
Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions.
KOLIBRI
Next-generation cell-culture platform to unlock biologics manufacturing, starting with gene therapies
Kalbe Genexine Biologics
Kalbe Genexine Biologics is developing innovative biologic therapy for high unmet medical needs in largely underserved areas.
Kingdom Supercultures
Kingdom Supercultures create microbial cultures that help food manufacturers to create new foods with boosted benefits.
Parse Biosciences
Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.
SCM Lifescience
SCM Lifescience is engaged in the research and development of medicines, hair care medicines, stem cell products.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
SynerGenetics Bioscience
SynerGenetics Bioscience is a plant genetics research and development company focused on developing high-yield CBD hemp strains/seeds.
Sensosan Società Benefit
Sensosan's mission is to resolve a huge problem by improving the well-being of people.
Sinovent
Sinovent is engaged in the technical development, consulting, and services of biological medicines.
Digzyme
Digzyme is a research and development platform for creating, discovering, and evaluating new enzyme-catalyzed reactions by bioinformatics.
DiogenX
DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.
DotBio
DotBio develops multi-functional antibodies based on its proprietary DotBody technology as the next generation of cancer therapies.
D3 Bio
D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines.
Epsilogen
Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.
Igenesis
Igenesis is a biotechnology company that provides molecular diagnostic technologies.
InxMed
InxMed is a clinical-stage biotech company dedicated to developing innovative, individualized medicines with international impact.
immunitoAI
ImmunitoAI is a life sciences (biotech) platform that leverages AI to revolutionize antibody discovery & therapeutics.
ImmunoScape
ImmunoScape offers a tech platform that allows profiling and characterization of the human immune response.
ILC Therapeutics
ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.
Inso Biosciences
Inso Bio is a Cornell University-based early-stage biotech company that develops platform technology for biological sample processing.
GRA&GREEN
GRA&GREEN is a research and development agribio venture based in Japan
GlobalYeast
GlobalYeast is a biotechnology startup focused on developing and deploying products and solutions for the industry.
Great Bay Bio
Great Bay Bio is a high-tech company developing blue ocean biopharmaceuticals with a digital CMC platform.
Greenlight Biosciences
GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.
Genome & Co.
Genome & Co (G&C) is a microbiome based research and development company focused on researching microbes and probiotics.
Genomics Medicine Ireland
Genomics Medicine Ireland is an Irish life sciences company conducting a study across Ireland of the human genome.
GangaGen
GangaGen is a clinical-stage biotechnology company focused on developing novel therapeutic proteins
GenomSys
GenomSys is a Swiss company composed by engineers with extensive experience in research, development and project management.
GATC Health
GATC Health is a technology company that develops predictive multi-omics advanced technology.
Octant Bio
Octant Bio is a developer of synthetic technology used to improve health and treat disease.
OriCiro Genomics
OriCiro Genomics creates a better Bioeconomy with innovative genome technologies.
Circular Code Biology
Ring Code Bio is a biomedical company that develops nucleic acid drugs based on a unique circular RNA technology platform.
Capsida
Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.
Centrillion Technologies
Centrillion Biosciences develops genomics and DNA analyses technology for personalized medicine, life sciences research, and bioinformatics.
Compson Agricultural Technology
Compson Agricultural Technology is a genetic technology company engaged in molecular breeding to solve problems in breeding livestock.
CureGenetics
Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.
Pardes Biosciences
Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.
Pyramid Biosciences
Pyramid Biosciences is a provider of biotechnological services.
Progenes
Progenes is a biotechnology startup that helps users find optimal nutrition and training according to their genetics.
Phytoform Labs
Phytoform Labs is a biotechnology company that focuses on resilient and sustainable crops.
Psilera Bioscience
Psilera Bioscience reimagining psychoactive natural products as building blocks for a new generation of mindful medicine.
Panacea Life Sciences
Panacea is a a woman-owned and woman-led company, is dedicated to developing and producing the highest-quality, medically-relevant, legal.
Current Employees Featured
Founder
Investors List
Fortune Ocean Growth Fund
Fortune Ocean Growth Fund investment in Series C - Abogen Biosciences
5Y Capital
5Y Capital investment in Series C - Abogen Biosciences
Jinyi Capital
Jinyi Capital investment in Series C - Abogen Biosciences
New Frontier Health
New Frontier Health investment in Series C - Abogen Biosciences
MiraeAsset Financial Group
MiraeAsset Financial Group investment in Series C - Abogen Biosciences
SoftBank Vision Fund
SoftBank Vision Fund investment in Series C - Abogen Biosciences
IMO Ventures
IMO Ventures investment in Series C - Abogen Biosciences
DNE Capital Management
DNE Capital Management investment in Series C - Abogen Biosciences
Chimera Investment
Chimera Investment investment in Series C - Abogen Biosciences
Firstred Capital
Firstred Capital investment in Series C - Abogen Biosciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-09-29 | Zhenzhi Yixue Keji | Abogen Biosciences investment in Seed Round - Zhenzhi Yixue Keji | N/A |
More informations about "Abogen Biosciences"
Abogen Biosciences - Crunchbase Investor Profile & Investments
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases. Lists …See details»
About Us - Abogenbio
About Us - AbogenbioSee details»
Abogen Biosciences - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Seed Round - Abogen …See details»
Abogen Biosciences - 2025 Company Profile - Tracxn
Abogen Biosciences. has raised a total funding of $1.13B over 5 rounds. Its first funding round was on Nov 05, 2020. What are the most recent funding rounds …See details»
AbogenBio 2025 Company Profile: Valuation, Funding & Investors …
AbogenBio General Information Description. Developer of mRNA drugs and vaccines for infectious diseases. The company operates a complete drug development pipeline from design, development, and production, enabling efficient delivery of new drugs.See details»
China's Abogen raises $700M series C for mRNA trials, …
Aug 20, 2021 Abogen Biosciences has raised one of the largest private biotech funding rounds ever. The low-profile biotech reeled in more than $700 million …See details»
China's mRNA vaccine technology firm Abogen raises over $700 mln
BEIJING, Aug 19 (Reuters) - China's Suzhou Abogen Biosciences said on Thursday it has raised over $700 million to support clinical development of its potential COVID-19 vaccine and …See details»
Suzhou Abogen Biosciences Co., Ltd. - Drug pipelines, Patents
Mar 9, 2025 Explore Suzhou Abogen Biosciences Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 9 clinical trials, 1 news, and 11 literature, Disease Domain:Infectious Diseases, Neoplasms, Hemic and Lymphatic Diseases, Immune System Diseases, Endocrinology and Metabolic Disease, Technology Platform:Prophylactic vaccine, mRNA vaccine, mRNA, …See details»
Abogen - Products, Competitors, Financials, Employees, …
Abogen operates as a plant-based pharmaceutical research company. It focuses on the research and development of messenger ribonucleic acid (mRNA) drugs to create antidotes against human disease. The company was founded in 2019 and is based in Suzhou, China.See details»
Abogen Biosciences - Updates, News, Events, Signals & Triggers
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics. Search Crunchbase. Start Free Trial . Chrome …See details»
Abogen - Crunchbase Company Profile & Funding
AboGen is a commercial-stage medical device company that has developed transformative technology: a saliva collection and preservation technology designed to preserve all the …See details»
Chinese mRNA vaccine developer Abogen raises $300 mln from …
Nov 29, 2021 BEIJING — Chinese mRNA technology firm Suzhou Abogen Biosciences said on Monday it had raised $300 million from investors including SoftBank Group Corp’s Vision …See details»
Abogen - VentureRadar
Abogen Biosciences is a leading biotech company focused on advancing mRNA science and technology to develop transformative therapies. The company has established an industry-leading proprietary mRNA platform and nanoparticle delivery system, enabling the delivery of the first EUA-granted China-developed COVID-19 mRNA vaccine. ...See details»
Dr. Bo Ying from Abogen Biosciences to Present Research Insights …
Dr. Bo Ying from Abogen Biosciences to Present Research Insights at mRNA-Based Therapeutics Summit in Europe. Pubdate:2024-12-31 22:00. The CEO of Abogen Biosciences will attend …See details»
China's mRNA vaccine technology firm Abogen raises over …
Aug 19, 2021 China's Suzhou Abogen Biosciences said on Thursday it has raised over $700 million to support clinical development of its potential COVID-19 vaccine and expand pipeline of other vaccine and ...See details»
Suzhou Abogen Biosciences Co., Ltd. (苏州艾博生物科 …
了解Suzhou Abogen Biosciences Co., Ltd. (苏州艾博生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的9项临床试验, 2篇新闻和11篇文献，疾病领域:感染，肿瘤，血液及淋巴系统疾病，免疫系统疾病，内分泌与代谢疾 …See details»
Abogen Biosciences - The Pharmaletter
Abogen, which was only founded in January 2019, will also put the money towards expanding its pipeline of other vaccine and treatment candidates. The Suzhou-headquartered firm is jointly developing its COVID-19 jab with a research institute affiliated with Chinese military and China-based vaccine producer Walvax Biotechnology.See details»
Suzhou Abogen Biosciences | LinkedIn
Suzhou Abogen Biosciences | 329 followers on LinkedIn. Abogen is a platform-based biotechnology company based on mRNA drugs. Through mRNA instructions, the human body …See details»
China’s Abogen Raises $700M to Fund the First ... - GeneOnline News
Aug 20, 2021 Despite having only been around for three years, China’s biotech startup Abogen Biosciences (Abogen) has bagged another successful financial round in 2021. And it might be one of the biggest rounds yet in China’s biotech sector. Based in Suzhou’s Biobay area, Abogen raised $700 million in Series C, and the goal is to fund its mRNA vaccine and oncology …See details»
Suzhou Abogen Biosciences - SignalHire
The position of the CEO is occupied by Bo Ying. Its headquarters is located at Suzhou, Jiangsu Province, CN. The number of employees ranges from 1 to 25. The Suzhou Abogen …See details»